Detail of GM0034
Summary
The genetically modified enzybiotic, named LysK297 , constructed by Truncation strategy, decrease the lytic activity.With LysK297
Sequence Length: 357 AA.
Mass: 39727.5 Da.
Isoelectric Point: 9.84
Function: show faint activity in both the zymogram and turbidity reduction assays, but no detectable activity in either plate lysis or MIC assays
Construction
GM0034, constructed by Truncation strategy. No schema construted on GM0034
Details:
GM0034[1-297]: derive from protein I6X5A8 sequence 1-297
I6X5A8, 495 AA., the LysK from Staphylococcus phage Fi200W
Source: Staphylococcus phage Fi200W
196-369: IPR002502, the N-acetylmuramoyl-L-alanine amidase domain
409-481: IPR003646, the SH3-like domain, bacterial-type?
Linking to UniprotKB
Linging to InterPro
Domains and repeats
29-160: IPR007921, the CHAP domain196-369: IPR002502, the N-acetylmuramoyl-L-alanine amidase domain
409-481: IPR003646, the SH3-like domain, bacterial-type?
GO term prediction
Molecular Function: 0008745, the N-acetylmuramoyl-L-alanine amidase activityLinking to UniprotKB
Linging to InterPro
Annotation
1-297
35-160
: EAD, CHAP domain, derived from staphylococcal bacteriophage endolysin LysK;197-297
: EAD, Amidase domain, derived from staphylococcal bacteriophage endolysin LysK;Domain and repeats:
29-160
: IPR007921,CHAP domain; GO term prediction:
MAKTQAEINKRLDAYAKGTVDSPYRVKKATSYDPSFGVMEAGAIDADGYYHAQCQDLITDYVLWLTDNKVRTWGNAKDQIKQSYGTGFKIHENKPSTVPKKGWIAVFTSGSYEQWGHIGIVYDGGNTSTFTILEQNWNGYANKKPTKRVDNYYGLTHFIEIPVKAGTTVKKETAKKSASKTPAPKKKATLKVSKNHINYTMDKRGKKPEGMVIHNDAGRSSGQQYENSLANAGYARYANGIAHYYGSEGYVWEAIDAKNQIAWHTGDGTGANSGNFRFAGIEVCQSMSASDAQFLKNEQAVFQFTAEKFKEWGLTPNRKTVRLHMEFVPTACPHRSMVLHTGFNPVTQGRPSQAIMN